AB&B BIO-TECH-B (02627) Selected for Inclusion in Hang Seng Composite Index

Stock News
02/16

AB&B BIO-TECH-B (02627) announced that its H-shares have been selected and will be included as a constituent stock of the Hang Seng Composite Index, effective from March 9, 2026. The Hang Seng Composite Index serves as a comprehensive H-share benchmark, covering companies listed on the Main Board of the Hong Kong Exchange that collectively represent the top 95% of cumulative market capitalization. It is widely used by index funds, mutual funds, and performance evaluation systems. The Board of Directors believes that the company's inclusion in the Hang Seng Composite Index reflects capital market recognition of its business performance and growth prospects. The Board is confident that this inclusion will help broaden the company's shareholder base, enhance the trading liquidity of its H-shares, and further strengthen its reputation and brand visibility.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10